SHARx Calls for Accountability in PBM Practices Amid Rising Drug Costs
As policymakers and employers increasingly scrutinize Pharmacy Benefit Managers (PBMs), SHARx is highlighting concerns over the lack of transparency and control within the prescription drug system. PBMs influence pricing, coverage, and access decisions with limited visibility to employers who fund healthcare costs.
Topics: drug costs employer healthcare spending PBMs transparency